UAB "Centralpharma Communications" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
125,000 |
50,201 |
1,589 |
1,509 |
606 |
76.95 |
1.21 |
23,506 |
2,837 |
220 |
25,597 |
2023 |
---|
121,500 |
40,500 |
1,073 |
1,019 |
340 |
89.01 |
0.84 |
24,525 |
2,651 |
89 |
26,878 |
2024 |
---|
207,500 |
56,081 |
441 |
416 |
112 |
89.35 |
0.20 |
24,941 |
4,299 |
947 |
27,951 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
207,500 €71 % *
Sales per employee (€)
56,081 €38 % *
Profit before tax (€)
441 €-59 % *
Net Profit (€)
416 €-59 % *
Profit per employee (€)
112 €-67 % *
Total profitability (%)
89.35 %0.38 % *
Net profitability (%)
0.20 %-76.19 % *
Equity (€)
24,941 €2 % *
Amounts Payable And Liabilities (€)
4,299 €62 % *
Non-current Assets (€)
947 €964 % *
CurrentAssets (€)
27,951 €4 % *